Product Images Gabapentin

This is a dosage table for Gabapentin based on renal function. The table provides the dosage range for patients with different levels of creatinine clearance, measured in mL/min. The dosages are divided into Total Daily Dose and Post-Hemodialysis Supplemental Dose. The table also includes the dosing frequency acronyms TID, BID, and QD, which respectively stand for three times a day, two times a day, and a single daily dose. Patients with creatinine clearance <15 mL/min should receive a reduced daily dose. Patients on hemodialysis should receive maintenance doses based on creatinine clearance estimates and a supplemental post-hemodialysis dose.*

This text seems to be a formula or calculation for estimating creatinine clearance (CLCy) based on the weight of the patient in kilograms and their serum creatinine level in milligrams per deciliter. The formula includes a coefficient of 0.85 for female patients. However, the text is incomplete and it is difficult to provide more context or a specific interpretation without additional information.*

This is a table containing information about the risk of antiepileptic drugs. The table lists indications such as epilepsy, psychiatric disorders, and others, along with the number of events per 1000 patients. The data is broken down into two categories: placebo patients and drug patients. A relative risk analysis is also given, as well as a risk difference analysis, both of which are based on the incidence of events in drug patients compared to placebo patients. No additional information is available.*

The text is a chart showing the mean pain score during a dose titration period and a fixed dose period of 8 weeks. The chart includes a placebo group and a group taking 3600 mg/day of Gabapentin. There is no further context or explanation provided.*

The text is a graph description showing the proportion of responders with more than 50% reduction in pain score in controlled postherpetic neuralgia (PHN) studies. The graph shows two studies, Study 1 and Study 2, with Study 2 having a higher response rate of 34%. The numbers at the end appear to be dosages or treatments used in the studies.*

Description: Gabapentin Tab 600mg (CV) is a medication manufactured by Cipla USA Inc. It is a generic product for Neurontin and each tablet contains 600mg Gabapentin. The package size, expiration date, and batch number are provided on the label.*